Skip to content

Thermo Fisher Scientific

NYSE: TMO · USD

Thermo Fisher Scientific cash flow and EPS85

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$1,625M
Thermo Fisher Scientific capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q219.94% · $31.8M80.06% · $127.7MUnavailableUnavailableUnavailable100% · $159.5M
FY 2009 Q381.84% · $42.8M18.16% · $9.5M0% · $0MUnavailable0% · $0M100% · $52.3M
FY 2009 Q46.93% · $81.7M40.87% · $481.8M0% · $0MUnavailable52.21% · $615.5M100% · $1,179M
FY 2010 Q110.4% · $50.6M47.08% · $229.1M0% · $0MUnavailable42.52% · $206.9M100% · $486.6M
FY 2010 Q28.36% · $58.4M8.4% · $58.7M26.84% · $187.5MUnavailable56.39% · $393.9M100% · $698.5M
FY 2010 Q38.1% · $64.6M32.31% · $257.6M59.58% · $475MUnavailable0% · $0M100% · $797.2M
FY 2010 Q418.28% · $91.9M12.09% · $60.8M69.62% · $350MUnavailable0% · $0M100% · $502.7M
FY 2011 Q19.65% · $63.7M3.59% · $23.7M81.43% · $537.5MUnavailable5.33% · $35.2M100% · $660.1M
FY 2011 Q22.14% · $59.2M74.68% · $2,067.6M8.13% · $225MUnavailable15.05% · $416.8M100% · $2,768.6M
FY 2011 Q31.61% · $62.6M92.62% · $3,608.1M5.78% · $225MUnavailable0% · $0M100% · $3,895.7M
FY 2011 Q418.79% · $81MUnavailable81.21% · $350MUnavailable0% · $0M100% · $431M
FY 2012 Q118.76% · $69.4M0.14% · $0.5M81.1% · $300M0% · $0M0% · $0M100% · $369.9M
FY 2012 Q216.69% · $65.3M45.55% · $178.2M25.56% · $100M12.19% · $47.7M0% · $0M100% · $391.2M
FY 2012 Q35.36% · $76M63.06% · $893.7M28.22% · $400M3.36% · $47.6MUnavailable100% · $1,417.3M
FY 2012 Q420.38% · $104.4M2.15% · $11M68.32% · $350M9.15% · $46.9MUnavailable100% · $512.3M
FY 2013 Q130.9% · $66M1.78% · $3.8M42.04% · $89.8M25.28% · $54MUnavailable100% · $213.6M
FY 2013 Q254.49% · $65.6M0.75% · $0.9M0% · $0M44.77% · $53.9MUnavailable100% · $120.4M
FY 2013 Q350.63% · $56.3M0.72% · $0.8M0% · $0M48.65% · $54.1MUnavailable100% · $111.2M
FY 2013 Q461.13% · $94.5M3.82% · $5.9M0% · $0M35.06% · $54.2MUnavailable100% · $154.6M
FY 2014 Q10.79% · $104.7M98.79% · $13,056.3M0% · $0M0.42% · $54.9MUnavailable100% · $13,215.9M
FY 2014 Q255.8% · $75.5MUnavailable0% · $0M44.2% · $59.8MUnavailable100% · $135.3M
FY 2014 Q359.51% · $90.7M1.05% · $1.6M0% · $0M39.44% · $60.1MUnavailable100% · $152.4M
FY 2014 Q412.47% · $156.7M0.32% · $4M0% · $0M4.78% · $60M82.43% · $1,035.7M100% · $1,256.4M
FY 2015 Q15.38% · $97.2M16.52% · $298.6M27.65% · $500M3.36% · $60.8M47.09% · $851.4M100% · $1,808M
FY 2015 Q211.1% · $95.3M0% · $0M0% · $0M6.96% · $59.7M81.94% · $703.3M100% · $858.3M
FY 2015 Q39.22% · $101M0.68% · $7.4M0% · $0M5.5% · $60.2M84.6% · $926.3M100% · $1,094.9M
FY 2015 Q46.89% · $129.4M20.7% · $388.6M0% · $0M3.19% · $59.9M69.21% · $1,299.2M100% · $1,877.1M
FY 2016 Q15.21% · $115.1M46.73% · $1,032.4M45.27% · $1,000M2.73% · $60.3M0.06% · $1.4M100% · $2,209.2M
FY 2016 Q26.36% · $114.8M0.04% · $0.7M0% · $0M3.27% · $59.1M90.33% · $1,631M100% · $1,805.6M
FY 2016 Q31.64% · $81M83.48% · $4,119.9M0% · $0M1.21% · $59.8M13.67% · $674.7M100% · $4,935.4M
FY 2016 Q45.33% · $133.5M1.41% · $35.4M9.98% · $250M2.36% · $59.2M80.92% · $2,027.1M100% · $2,505.2M
FY 2017 Q15.64% · $93.4M18.15% · $300.7M30.19% · $500M3.57% · $59.1M42.45% · $703.2M100% · $1,656.4M
FY 2017 Q28.55% · $88M0.61% · $6.3M24.3% · $250M5.71% · $58.7M60.82% · $625.7M100% · $1,028.7M
FY 2017 Q31.35% · $111.4M83.1% · $6,853.2M0% · $0M0.72% · $59.3M14.83% · $1,222.8M100% · $8,246.7M
FY 2017 Q419.78% · $215.2M6.05% · $65.8M0% · $0M5.5% · $59.9M68.67% · $747.3M100% · $1,088.2M
FY 2018 Q117.15% · $118M8.28% · $57M0% · $0M8.72% · $60M65.84% · $453M100% · $688M
FY 2018 Q215.86% · $183M0.17% · $2M0% · $0M5.98% · $69M77.99% · $900M100% · $1,154M
FY 2018 Q314.57% · $173M0% · $0M21.06% · $250M5.81% · $69M58.55% · $695M100% · $1,187M
FY 2018 Q426.22% · $284M44.04% · $477M23.08% · $250M6.28% · $68M0.37% · $4M100% · $1,083M
FY 2019 Q119.69% · $201M0.1% · $1M73.46% · $750M6.66% · $68M0.1% · $1M100% · $1,021M
FY 2019 Q211.09% · $220M84.97% · $1,685M0% · $0M3.83% · $76M0.1% · $2M100% · $1,983M
FY 2019 Q310.84% · $216M0.05% · $1M0% · $0M3.86% · $77M85.25% · $1,699M100% · $1,993M
FY 2019 Q44.87% · $289M2.63% · $156M12.65% · $750M1.28% · $76M78.56% · $4,658M100% · $5,929M
FY 2020 Q113.79% · $253M0.22% · $4M81.79% · $1,500M4.14% · $76M0.05% · $1M100% · $1,834M
FY 2020 Q275.35% · $269MUnavailable0% · $0M24.37% · $87M0.28% · $1M100% · $357M
FY 2020 Q331.47% · $366M0% · $0M0% · $0M7.48% · $87M61.05% · $710M100% · $1,163M
FY 2020 Q482.65% · $586M4.94% · $35M0% · $0M12.27% · $87M0.14% · $1M100% · $709M
FY 2021 Q19.15% · $628M19.57% · $1,343M29.15% · $2,000M1.27% · $87M40.86% · $2,804M100% · $6,862M
FY 2021 Q274.38% · $540M11.29% · $82M0% · $0M14.19% · $103M0.14% · $1M100% · $726M
FY 2021 Q372.58% · $524M13.02% · $94M0% · $0M14.13% · $102M0.28% · $2M100% · $722M
FY 2021 Q43% · $831M64.44% · $17,876M0% · $0M0.37% · $103M32.19% · $8,931M100% · $27,741M
FY 2022 Q120.27% · $640M1.27% · $40M63.33% · $2,000M3.26% · $103M11.87% · $375M100% · $3,158M
FY 2022 Q281.22% · $506M0% · $0M0% · $0M18.78% · $117M0% · $0M100% · $623M
FY 2022 Q382.26% · $547MUnavailable0% · $0M17.74% · $118M0% · $0M100% · $665M
FY 2022 Q432.99% · $550M0% · $0M59.99% · $1,000M7.02% · $117M0% · $0M100% · $1,667M
FY 2023 Q17.29% · $458M43.06% · $2,704M47.78% · $3,000M1.86% · $117M0% · $0M100% · $6,279M
FY 2023 Q219.37% · $284M3.21% · $47M0% · $0M9.21% · $135M68.21% · $1,000M100% · $1,466M
FY 2023 Q313.97% · $332M38.26% · $909M0% · $0M5.68% · $135M42.09% · $1,000M100% · $2,376M
FY 2023 Q49.37% · $405M0% · $0M0% · $0M3.15% · $136M87.49% · $3,782M100% · $4,323M
FY 2024 Q19.97% · $347M0% · $0M86.16% · $3,000M3.88% · $135M0% · $0M100% · $3,482M
FY 2024 Q266.89% · $301M0% · $0M0% · $0M33.11% · $149M0% · $0M100% · $450M
FY 2024 Q35.84% · $272M67.2% · $3,132M0% · $0M3.22% · $150M23.75% · $1,107M100% · $4,661M
FY 2024 Q411.63% · $480M0% · $0M24.22% · $1,000M3.61% · $149M60.55% · $2,500M100% · $4,129M
FY 2025 Q110.81% · $362M0% · $0M59.72% · $2,000M4.45% · $149M25.02% · $838M100% · $3,349M
FY 2025 Q223.65% · $294M0% · $0M0% · $0M13.03% · $162M63.31% · $787M100% · $1,243M
FY 2025 Q37.26% · $404M72.52% · $4,037M17.3% · $963M2.93% · $163M0% · $0M100% · $5,567M
FY 2025 Q432.05% · $465M0% · $0M2.55% · $37M11.16% · $162M54.24% · $787M100% · $1,451M
FY 2026 Q12.72% · $376M64.19% · $8,872M21.7% · $3,000M1.17% · $162M10.22% · $1,412M100% · $13,822M
FY 2026 Q227.69% · $450M0% · $0M61.54% · $1,000M10.77% · $175M0% · $0M100% · $1,625M
Jun 27, 2009 through Jun 27, 2026

Operating cash flow

USD millions

$2,125M

Capital expenditures

USD millions

$450M

Free cash flow

USD millions

$1,675M

Stock-based compensation

USD millions

$82M

SBC / free cash flow

% · FCF before SBC deduction

4.9%

SBC / operating cash flow

%

3.86%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$4.68

Quarterly data

Thermo Fisher Scientific cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 27, 20262,1254501,675824.9%3.86%—$4.68
FY 2026 Q1Mar 28, 20261,1923768168310.17%6.96%—$4.43
FY 2025 Q4Dec 31, 20253,4574652,992842.81%2.43%——
FY 2025 Q3Sep 27, 20252,2394041,835703.81%3.13%—$4.27
FY 2025 Q2Jun 28, 20251,3992941,105817.33%5.79%—$4.28
FY 2025 Q1Mar 29, 20257233623617520.78%10.37%—$3.98
FY 2024 Q4Dec 31, 20243,2904802,810792.81%2.4%——
FY 2024 Q3Sep 28, 20242,1662721,894683.59%3.14%—$4.25
FY 2024 Q2Jun 29, 20241,9603011,659845.06%4.29%—$4.04
FY 2024 Q1Mar 30, 20241,251347904707.74%5.6%—$3.46
FY 2023 Q4Dec 31, 20233,7234053,318611.84%1.64%——
FY 2023 Q3Sep 30, 20232,4143322,082673.22%2.78%—$4.42
FY 2023 Q2Jul 1, 20231,5402841,256745.89%4.81%—$3.51
FY 2023 Q1Apr 1, 20237294582717628.04%10.43%—$3.32
FY 2022 Q4Dec 31, 20223,4875502,937752.55%2.15%——
FY 2022 Q3Oct 1, 20221,9375471,390775.54%3.98%—$3.79
FY 2022 Q2Jul 2, 20221,5285061,022777.53%5.04%—$4.22
FY 2022 Q1Apr 2, 20222,2026401,562784.99%3.54%—$5.61
FY 2021 Q4Dec 31, 20212,4578311,626774.74%3.13%——
FY 2021 Q3Oct 2, 20212,6505242,126512.4%1.92%—$4.79
FY 2021 Q2Jul 3, 20212,2275401,687513.02%2.29%—$4.61
FY 2021 Q1Apr 3, 20211,9786281,350513.78%2.58%—$5.88
FY 2020 Q4Dec 31, 20203,3395862,753511.85%1.53%——
FY 2020 Q3Sep 26, 20202,7083662,342522.22%1.92%—$4.84
FY 2020 Q2Jun 27, 20201,8862691,617472.91%2.49%—$2.9
FY 2020 Q1Mar 28, 20203562531034644.66%12.92%—$1.97
FY 2019 Q4Dec 31, 20191,9132891,624432.65%2.25%—$2.49
FY 2019 Q3Sep 28, 20191,117216901424.66%3.76%—$1.88
FY 2019 Q2Jun 29, 20191,2942201,074524.84%4.02%—$2.77
FY 2019 Q1Mar 30, 2019649201448449.82%6.78%—$2.02
FY 2018 Q4Dec 31, 20181,8012841,517442.9%2.44%—$2.22
FY 2018 Q3Sep 29, 20181,2201731,047464.39%3.77%—$1.75
FY 2018 Q2Jun 30, 20181,4441831,261483.81%3.32%—$1.85
FY 2018 Q1Mar 31, 201878118-4043—55.13%—$1.43
FY 2017 Q4Dec 31, 20171,866.5215.21,651.343.12.61%2.31%—$1.3
FY 2017 Q3Sep 30, 2017928.6111.4817.244.75.47%4.81%—$1.34
FY 2017 Q2Jul 1, 2017848.488760.438.25.02%4.5%—$1.56
FY 2017 Q1Apr 1, 2017361.593.4268.13312.31%9.13%—$1.4
FY 2016 Q4Dec 31, 20161,205.9133.51,072.431.52.94%2.61%—$1.59
FY 2016 Q3Oct 1, 2016771.881690.834.95.05%4.52%—$1.19
FY 2016 Q2Jul 2, 2016889.5114.8774.733.74.35%3.79%—$1.3
FY 2016 Q1Apr 2, 2016289.1115.117433.419.2%11.55%—$1.01
FY 2015 Q4Dec 31, 20151,228.1129.41,098.733.23.02%2.7%—$1.5
FY 2015 Q3Sep 26, 2015743.9101642.932.55.06%4.37%—$1.18
FY 2015 Q2Jun 27, 2015764.995.3669.631.14.64%4.07%—$1.27
FY 2015 Q1Mar 28, 20158097.2-17.228.2—35.25%—$0.96
FY 2014 Q4Dec 31, 2014953.7156.779730.53.83%3.2%—$1.49
FY 2014 Q3Sep 27, 201467690.7585.330.65.23%4.53%—$1.17
FY 2014 Q2Jun 28, 2014888.775.5813.230.83.79%3.47%—$0.69
FY 2014 Q1Mar 29, 2014101.2104.7-3.525.2—24.9%—$1.36
FY 2013 Q4Dec 31, 2013728.594.563424.33.83%3.34%—$0.92
FY 2013 Q3Sep 28, 2013505.556.3449.222.95.1%4.53%—$0.86
FY 2013 Q2Jun 29, 2013478.465.6412.823.35.64%4.87%—$0.76
FY 2013 Q1Mar 30, 2013298.366232.320.48.78%6.84%—$0.93
FY 2012 Q4Dec 31, 2012660.1104.4555.720.43.67%3.09%—$1.04
FY 2012 Q3Sep 29, 2012479.976403.920.35.03%4.23%—$0.79
FY 2012 Q2Jun 30, 2012507.565.3442.220.34.59%4%—$0.63
FY 2012 Q1Mar 31, 201239269.4322.617.35.36%4.41%—$0.75
FY 2011 Q4Dec 31, 20116378155619.53.51%3.06%—$0.77
FY 2011 Q3Oct 1, 2011360.762.6298.118.86.31%5.21%—$0.69
FY 2011 Q2Jul 2, 2011354.759.2295.520.36.87%5.72%—$1.36
FY 2011 Q1Apr 2, 2011338.663.7274.921.67.86%6.38%—$0.64
FY 2010 Q4Dec 31, 2010438.291.9346.320.55.92%4.68%——
FY 2010 Q3Oct 2, 2010432.864.6368.221.25.76%4.9%—$0.66
FY 2010 Q2Jul 3, 2010283.758.4225.322.39.9%7.86%—$0.57
FY 2010 Q1Apr 3, 2010343.150.6292.519.16.53%5.57%—$0.56
FY 2009 Q4Dec 31, 2009538.681.7456.911.72.56%2.17%—$0.65
FY 2009 Q3Sep 26, 2009386.642.8343.820.65.99%5.33%—$530,000
FY 2009 Q2Jun 27, 2009375.331.8343.520.66%5.49%—$0.49
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · TMO, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.